Activities for students and lesson plan ideas based on Times articles, photos, videos and graphs. What Rites of Passage Do You Celebrate? Boys are celebrating their transition into adulthood with ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

15, 2025 — Regular aerobic exercise could significantly reduce disease markers associated with Alzheimer's, new research has ... in adults supports verbal learning and memory, which enables ...

But each job doesn't necessarily require a separate box; active speakers – i.e. speakers with built-in amplification – can perform two of those roles, meaning all you need to complete the hi-fi ...

Samsung is working on a new rugged tablet, the Galaxy Tab Active 5 Pro, powered by the Snapdragon 7s Gen 3. The company is also working on the Galaxy Tab S10 FE and Tab S10 FE Plus, powered by the ...

Primary progressive aphasia (PPA) may develop in people with Alzheimer’s disease. Aphasia is an impairment of speech and language comprehension which also affects the ability to read and write.

In addition to the most cutting-edge and expert-backed smarter living advice in the categories of wellness, health, ...

By The Learning Network Look closely at this image, stripped of its caption, and join the moderated conversation about what you and other students see. By The Learning Network Want to use ...

Send your kids to these sites to help them learn, study, indulge their curiosity, and get a fresh perspective on academic subjects. I've been contributing to PCMag since 2011 in a variety of ways ...

The Ati-Atihan Festival, often referred to as the “Mother of All Philippine Festivals,” is a vibrant and deeply rooted tradition held annually in Kalibo, Aklan. Scheduled for January 2025, the ...

The Montreal Cognitive Assessment (MoCA) is a test used to detect mild cognitive decline and early signs of dementia. It can help identify people at risk of Alzheimer's disease and screen for ...

Progress in dementia research and clinical care has continued to accelerate in 2024. Monoclonal antibody anti-amyloid immunotherapies (AATs) have been approved for clinical use for patients with mild ...